Inhaled Beclomethasone to Prevent Chronic Lung Disease

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-02-18

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

To test if inhaled glucocorticoids, early in the course of respiratory failure in premature infants, permit normal lung growth and differentiation, thus preventing development of bronchopulmonary dysplasia.

CONDITIONS

Brief Title

Inhaled Beclomethasone to Prevent Chronic Lung Disease

Who Can Participate

Age: 0 - 1Year

All Genders

Eligibility Criteria

Premature boy and girl infants with birth weight less than 1,251 grams, gestational age less than 33 weeks, and postnatal age three to fourteen days, who continue to require mechanical ventilation with an emphasis on enrollment at three days.